ATL1103 (COR-004) Higher Dose Study - Dosing Commenced
Released
Latest announcements
Ask a question
Your question will be sent privately to Percheron Therapeutics. The company may choose to make this question public.
Investor Q&As
Start the conversation
Ask Percheron Therapeutics a question about this announcement.